Consun Pharmaceutical Group Limited (HKG:1681)

HKG:1681 Revenue

Consun Pharmaceutical Group had revenue of 1.27B CNY in the half year ending June 30, 2024, with 27.68% growth. This brings the company's revenue in the last twelve months to 2.74B, up 11.08% year-over-year. In the year 2023, Consun Pharmaceutical Group had annual revenue of 2.59B with 10.71% growth.

• Revenue (ttm): 2.74B CNY
• Revenue Growth: +11.08%
• P/S Ratio: 2.20
• Revenue / Employee: 875.91K CNY
• Employees: 3,127
• Market Cap: 6.74B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.59B	250.47M	10.71%
Dec 31, 2022	2.34B	294.99M	14.43%
Dec 31, 2021	2.04B	291.83M	16.65%
Dec 31, 2020	1.75B	24.57M	1.42%
Dec 31, 2019	1.73B	-115.72M	-6.28%